Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.
Denisa ErhartovaMonika CahovaHelena DankovaMarie HeczkovaIrena MikovaEva SticovaJulius SpicakOndřej ŠedaPavel TruneckaPublished in: PloS one (2019)
Our data indicate that circulating miR-33a is an independent predictor of liver steatosis and inflammation in patients after liver transplantation. Although statistically significant, its contribution to the accuracy of prediction model employing readily available clinical and biochemical variables was limited in our cohort.
Keyphrases
- cell proliferation
- long non coding rna
- end stage renal disease
- oxidative stress
- insulin resistance
- ejection fraction
- high fat diet
- long noncoding rna
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- type diabetes
- high fat diet induced
- big data
- patient reported outcomes
- adipose tissue
- machine learning
- skeletal muscle